+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro



Copper induces--and copper chelation by tetrathiomolybdate inhibits--endothelial activation in vitro



Redox Report 19(1): 40-48



Endothelial activation with increased expression of cellular adhesion molecules and chemokines critically contributes to vascular inflammation and atherogenesis. Redox-active transition metal ions play an important role in vascular oxidative stress and inflammation. Therefore, the goal of the present study was to investigate the role of copper in endothelial activation and the potential anti-inflammatory effects of copper chelation by tetrathiomolybdate (TTM) in human aortic endothelial cells (HAECs). Incubating HAECs with cupric sulfate dose- and time-dependently increased mRNA and protein expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and monocyte chemotactic protein-1 (MCP-1). Copper also activated the redox-sensitive transcription factors, nuclear factor kappa B (NF-κB) and activator protein-1 (AP-1), which was inhibited by pretreatment of the cells with TTM. Furthermore, TTM dose-dependently inhibited tumor necrosis factor α (TNFα)-induced activation of NF-κB and AP-1, as well as mRNA and protein expression of VCAM-1, ICAM-1, and MCP-1, which was abolished by preincubating the cells with 5 µM TTM and 15 µM cupric sulfate. The inhibitory effect of TTM on TNFα-induced NF-κB activation was associated with decreased phosphorylation and degradation of IκBα. These data suggest that intracellular copper causes activation of redox-sensitive transcription factors and upregulation of inflammatory mediators in endothelial cells. Copper chelation by TTM may attenuate TNFα-induced endothelial activation and, hence, inhibit vascular inflammation and atherosclerosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052344910

Download citation: RISBibTeXText

PMID: 24225134

DOI: 10.1179/1351000213y.0000000070


Related references

Intracellular copper chelation by tetrathiomolybdate inhibits endothelial activation in vitro and in vivo. 2007

Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo. American Journal of Physiology. Heart and Circulatory Physiology 301(3): H712-H720, 2011

Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 223(2): 306-313, 2012

Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm. Expert Opinion on Investigational Drugs 18(4): 541-548, 2009

Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats. Arthritis Research and Therapy 7(6): R1174-R1182, 2005

Rates of change in liver copper concentration in cattle given a copper-deficient diet, with or without pre-treatment with tetrathiomolybdate, for evaluation of two parenteral copper supplements. New Zealand Veterinary Journal 61(3): 154-158, 2013

Profiles of copper 67 in blood bile urine and feces from copper 67 primed lambs effect of molybdenum labelled tetrathiomolybdate on the metabolism of recently stored tissue copper 67. British Journal of Nutrition 61(2): 355-372, 1989

Profiles of copper 67 in blood bile urine and feces from copper 67 primed lambs effect of molybdenum 99 labelled tetrathiomolybdate on the metabolism of copper 67 after long term storage. British Journal of Nutrition 61(2): 373-386, 1989

Copper chelation and exogenous copper affect circadian clock phase resetting in the suprachiasmatic nucleus in vitro. Neuroscience 256: 252-261, 2014

Iatrogenic copper deficiency associated with long-term copper chelation for treatment of copper storage disease in a Bedlington Terrier. Journal of the American Veterinary Medical Association 218(10): 1593-7 1580, 2001

Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1. Metallomics 10(5): 745-750, 2018

Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science 327(5963): 331-334, 2010

Copper chelation by tryptophan inhibits the copper-ascorbate oxidation of tryptophan. Redox Report 2(3): 191-197, 1996

Liver Distribution Of Copper And 99 Mo In Sheep Following Intravenous Administration Of Copper Sulfate And [ 99 Mo]-Tetrathiomolybdate. Canadian Journal of Animal Science 66(2): 563-565, 1986

Copper associated toxic encephalopathy in copper-poisoned sheep treated with tetrathiomolybdate (TTM). Trace elements in man and animals TEMA 8: Proceedings of the Eighth International Symposium on Trace Elements in Man and Animals: 982-984, 1993